SCLC cell lines, including DMS273 (c-MYC and MYCL amplification), H526 (MYCN amplification), and H196 (no MYC paralog amplification or overexpression) were selected for evaluation in vivo. The gene discussed is MYCL; the disease is small cell lung carcinoma.